Nu Skin Enterprises (NUS) Stock Forecast, Price Target & Predictions
NUS Stock Forecast
Nu Skin Enterprises stock forecast is as follows: an average price target of $11.00 (represents a 52.78% upside from NUS’s last price of $7.20) and a rating consensus of 'Strong Buy', based on 0 wall street analysts offering a 1-year stock forecast.
NUS Price Target
The average price target for Nu Skin Enterprises (NUS) is $11.00 based on 1-year price targets from 0 Wall Street analysts in the past 3 months, with a price target range of $11.00 to $11.00. This represents a potential 52.78% upside from NUS's last price of $7.20.
NUS Analyst Ratings
According to 0 Wall Street analysts, Nu Skin Enterprises's rating consensus is 'Strong Buy'. The analyst rating breakdown for NUS stock is 0 'Strong Buy' (NaN%), 0 'Buy' (NaN%), 0 'Hold' (NaN%), 0 'Sell' (NaN%), and 0 'Strong Sell' (NaN%).
Nu Skin Enterprises Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 12, 2024 | Linda Bolton Weiser | D.A. Davidson | $11.00 | $9.21 | 19.37% | 52.78% |
| Nov 23, 2022 | - | D.A. Davidson | $34.00 | $39.36 | -13.62% | 372.22% |
The latest Nu Skin Enterprises stock forecast, released on Aug 12, 2024 by Linda Bolton Weiser from D.A. Davidson, set a price target of $11.00, which represents a 19.37% increase from the stock price at the time of the forecast ($9.21), and a 52.78% increase from NUS last price ($7.20).
Nu Skin Enterprises Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $11.00 | $11.00 |
| Last Closing Price | $7.20 | $7.20 | $7.20 |
| Upside/Downside | -100.00% | 52.78% | 52.78% |
In the current month, the average price target of Nu Skin Enterprises stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nu Skin Enterprises's last price of $7.20. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 20, 2024 | Zacks Investment Research | Cautious | Cautious | Hold |
| Oct 23, 2023 | Cowen & Co. | Underperform | Underperform | Hold |
Nu Skin Enterprises's last stock rating was published by Zacks Investment Research on Aug 20, 2024. The company gave NUS a "Cautious" rating, the same as its previous rate.
Nu Skin Enterprises Financial Forecast
Nu Skin Enterprises Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $488.64M | $498.77M | $500.26M | $481.46M | $522.34M | $537.80M | - | $604.90M | $673.44M | $641.15M | $704.05M | $677.03M | $748.19M | $703.35M | $612.37M | $518.03M | $583.36M | $589.93M | $623.50M | $623.62M | $683.29M | $675.31M |
| Avg Forecast | $463.35M | $451.20M | $450.05M | $427.70M | $456.61M | $440.59M | $431.87M | $426.55M | $476.39M | $520.09M | $509.30M | $477.49M | $542.32M | $569.82M | $574.11M | $579.69M | $655.93M | $639.89M | $702.54M | $635.40M | $749.73M | $689.59M | $583.93M | $480.84M | $582.08M | $606.27M | $622.42M | $615.84M | $683.29M | $704.05M |
| High Forecast | $467.01M | $454.76M | $453.60M | $431.08M | $460.22M | $444.07M | $435.28M | $429.92M | $478.63M | $529.07M | $513.32M | $481.27M | $546.61M | $574.32M | $574.11M | $585.27M | $662.24M | $646.05M | $709.31M | $641.52M | $756.95M | $696.22M | $589.55M | $485.46M | $587.68M | $612.10M | $628.41M | $621.77M | $819.94M | $844.86M |
| Low Forecast | $460.23M | $448.16M | $447.02M | $424.82M | $453.53M | $437.62M | $428.96M | $423.67M | $474.14M | $509.99M | $505.86M | $474.27M | $538.67M | $565.98M | $574.11M | $573.51M | $648.93M | $633.06M | $695.04M | $628.62M | $741.73M | $682.22M | $577.70M | $475.70M | $575.86M | $599.80M | $615.78M | $609.26M | $546.63M | $563.24M |
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 11 |
| Surprise % | - | - | - | - | - | - | - | - | 1.03% | 0.96% | 0.98% | 1.01% | 0.96% | 0.94% | - | 1.04% | 1.03% | 1.00% | 1.00% | 1.07% | 1.00% | 1.02% | 1.05% | 1.08% | 1.00% | 0.97% | 1.00% | 1.01% | 1.00% | 0.96% |
Nu Skin Enterprises's average Quarter revenue forecast for Mar 24 based on 1 analysts is $426.55M, with a low forecast of $423.67M, and a high forecast of $429.92M. NUS's average Quarter revenue forecast represents a -12.71% decrease compared to the company's last Quarter revenue of $488.64M (Dec 23).
Nu Skin Enterprises EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 11 |
| EBITDA | - | - | - | - | - | - | - | - | $-28.89M | $-26.36M | $42.51M | $35.64M | $64.20M | $39.96M | - | $69.28M | $36.90M | $88.10M | $100.94M | $82.84M | $110.14M | $92.67M | $77.92M | $49.49M | $72.26M | $84.22M | $89.93M | $85.41M | $34.35M | $96.38M |
| Avg Forecast | $48.88M | $47.60M | $47.48M | $45.12M | $48.17M | $46.48M | $45.56M | $77.51M | $50.26M | $54.87M | $53.73M | $70.46M | $57.21M | $84.51M | $60.57M | $64.05M | $30.68M | $76.83M | $92.37M | $60.98M | $90.71M | $83.22M | $54.04M | $30.48M | $72.26M | $80.89M | $89.93M | $79.48M | $34.35M | $100.32M |
| High Forecast | $49.27M | $47.98M | $47.85M | $45.48M | $48.55M | $46.85M | $45.92M | $93.01M | $50.49M | $55.81M | $54.15M | $84.55M | $57.66M | $101.42M | $60.57M | $76.86M | $36.82M | $92.20M | $110.85M | $73.17M | $108.85M | $99.86M | $64.85M | $36.58M | $86.72M | $97.07M | $107.91M | $95.38M | $41.22M | $120.38M |
| Low Forecast | $48.55M | $47.28M | $47.16M | $44.82M | $47.85M | $46.17M | $45.25M | $62.00M | $50.02M | $53.80M | $53.37M | $56.37M | $56.83M | $67.61M | $60.57M | $51.24M | $24.55M | $61.46M | $73.90M | $48.78M | $72.57M | $66.57M | $43.23M | $24.39M | $57.81M | $64.71M | $71.94M | $63.58M | $27.48M | $80.25M |
| Surprise % | - | - | - | - | - | - | - | - | -0.57% | -0.48% | 0.79% | 0.51% | 1.12% | 0.47% | - | 1.08% | 1.20% | 1.15% | 1.09% | 1.36% | 1.21% | 1.11% | 1.44% | 1.62% | 1.00% | 1.04% | 1.00% | 1.07% | 1.00% | 0.96% |
3 analysts predict NUS's average Quarter EBITDA for Sep 23 to be $54.87M, with a high of $55.81M and a low of $53.80M. This is 29.08% upper than Nu Skin Enterprises's previous annual EBITDA (Jun 23) of $42.51M.
Nu Skin Enterprises Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 11 |
| Net Income | - | - | - | - | - | - | - | - | $7.28M | $-36.95M | $26.89M | $11.38M | $57.22M | $-25.39M | - | $38.72M | $-9.23M | $49.73M | $59.34M | $47.43M | $73.47M | $56.31M | $41.85M | $19.73M | $40.11M | $44.09M | $46.35M | $43.00M | $-17.76M | $53.15M |
| Avg Forecast | $16.15M | $10.68M | $14.91M | $10.43M | $14.16M | $10.05M | $8.31M | $44.24M | $-1.24M | $31.97M | $26.50M | $40.22M | $22.03M | $47.71M | $38.92M | $36.57M | $-7.68M | $43.37M | $54.30M | $34.91M | $60.50M | $50.56M | $29.03M | $12.15M | $40.11M | $42.35M | $46.35M | $40.02M | $-17.76M | $55.32M |
| High Forecast | $16.31M | $10.79M | $15.06M | $10.54M | $14.30M | $10.56M | $8.39M | $53.09M | $-1.02M | $35.57M | $26.77M | $48.27M | $22.25M | $57.25M | $38.92M | $43.88M | $-6.14M | $52.04M | $65.16M | $41.90M | $72.60M | $60.67M | $34.83M | $14.58M | $48.13M | $50.82M | $55.62M | $48.02M | $-14.21M | $66.38M |
| Low Forecast | $16.01M | $10.59M | $14.78M | $10.34M | $14.03M | $9.55M | $8.24M | $35.40M | $-1.46M | $29.39M | $26.27M | $32.18M | $21.83M | $38.16M | $38.92M | $29.25M | $-9.21M | $34.69M | $43.44M | $27.93M | $48.40M | $40.45M | $23.22M | $9.72M | $32.09M | $33.88M | $37.08M | $32.01M | $-21.31M | $44.25M |
| Surprise % | - | - | - | - | - | - | - | - | -5.86% | -1.16% | 1.01% | 0.28% | 2.60% | -0.53% | - | 1.06% | 1.20% | 1.15% | 1.09% | 1.36% | 1.21% | 1.11% | 1.44% | 1.62% | 1.00% | 1.04% | 1.00% | 1.07% | 1.00% | 0.96% |
Nu Skin Enterprises's average Quarter net income forecast for Mar 24 is $44.24M, with a range of $35.40M to $53.09M. NUS's average Quarter net income forecast represents a 507.58% increase compared to the company's last Quarter net income of $7.28M (Dec 23).
Nu Skin Enterprises SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 11 |
| SG&A | - | - | - | - | - | - | - | - | $326.36M | $318.63M | $322.21M | $322.02M | $328.69M | $354.46M | - | $391.25M | $427.47M | $416.86M | $446.70M | $443.55M | $464.75M | $445.75M | $400.18M | $355.67M | $388.11M | $379.88M | $395.27M | $408.31M | $432.32M | $437.18M |
| Avg Forecast | $298.98M | $291.14M | $290.40M | $275.98M | $294.64M | $284.30M | $278.67M | $275.24M | $307.40M | $335.60M | $328.63M | $406.47M | $349.94M | $399.90M | $370.45M | $369.52M | $355.48M | $363.54M | $408.78M | $326.50M | $382.73M | $400.26M | $277.55M | $219.09M | $388.11M | $364.88M | $395.27M | $379.95M | $432.32M | $455.02M |
| High Forecast | $301.35M | $293.44M | $292.70M | $278.16M | $296.96M | $286.54M | $280.87M | $277.41M | $308.84M | $341.39M | $331.23M | $487.76M | $352.71M | $479.87M | $370.45M | $443.42M | $426.57M | $436.25M | $490.53M | $391.80M | $459.28M | $480.31M | $333.05M | $262.91M | $465.74M | $437.86M | $474.32M | $455.94M | $518.78M | $546.03M |
| Low Forecast | $296.97M | $289.18M | $288.44M | $274.12M | $292.65M | $282.38M | $276.79M | $273.38M | $305.95M | $329.08M | $326.42M | $325.18M | $347.58M | $319.92M | $370.45M | $295.61M | $284.38M | $290.83M | $327.02M | $261.20M | $306.18M | $320.21M | $222.04M | $175.27M | $310.49M | $291.91M | $316.22M | $303.96M | $345.85M | $364.02M |
| Surprise % | - | - | - | - | - | - | - | - | 1.06% | 0.95% | 0.98% | 0.79% | 0.94% | 0.89% | - | 1.06% | 1.20% | 1.15% | 1.09% | 1.36% | 1.21% | 1.11% | 1.44% | 1.62% | 1.00% | 1.04% | 1.00% | 1.07% | 1.00% | 0.96% |
Nu Skin Enterprises's average Quarter SG&A projection for Mar 24 is $275.24M, based on 1 Wall Street analysts, with a range of $273.38M to $277.41M. The forecast indicates a -15.66% fall compared to NUS last annual SG&A of $326.36M (Dec 23).
Nu Skin Enterprises EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | - | - | 2 | 2 | 2 | 11 | 12 | 16 | 9 | 9 | 8 | 9 | 13 | 17 | 19 | 11 |
| EPS | - | - | - | - | - | - | - | - | $0.15 | $-0.74 | $0.54 | $0.23 | $1.16 | $-0.51 | - | $0.77 | $-0.19 | $0.99 | $1.18 | $0.94 | $1.43 | $1.10 | $0.81 | $0.36 | $0.72 | $0.79 | $0.83 | $0.78 | $-0.32 | $0.96 |
| Avg Forecast | $0.33 | $0.21 | $0.30 | $0.21 | $0.28 | $0.20 | $0.17 | $0.05 | $-0.03 | $0.64 | $0.53 | $0.30 | $0.44 | $0.37 | $0.79 | $0.72 | $0.95 | $0.86 | $1.05 | $0.73 | $1.19 | $1.00 | $0.60 | $0.25 | $0.72 | $0.76 | $0.83 | $0.71 | $1.05 | $1.02 |
| High Forecast | $0.33 | $0.22 | $0.30 | $0.21 | $0.29 | $0.21 | $0.17 | $0.05 | $-0.02 | $0.72 | $0.54 | $0.30 | $0.45 | $0.37 | $0.79 | $0.73 | $0.96 | $0.87 | $1.06 | $0.74 | $1.20 | $1.01 | $0.61 | $0.25 | $0.73 | $0.77 | $0.84 | $0.72 | $1.26 | $1.22 |
| Low Forecast | $0.32 | $0.21 | $0.30 | $0.21 | $0.28 | $0.19 | $0.17 | $0.05 | $-0.03 | $0.59 | $0.53 | $0.30 | $0.44 | $0.37 | $0.79 | $0.71 | $0.93 | $0.85 | $1.03 | $0.72 | $1.17 | $0.99 | $0.60 | $0.24 | $0.71 | $0.75 | $0.82 | $0.70 | $0.84 | $0.82 |
| Surprise % | - | - | - | - | - | - | - | - | -6.00% | -1.15% | 1.01% | 0.77% | 2.62% | -1.38% | - | 1.07% | -0.20% | 1.15% | 1.13% | 1.29% | 1.20% | 1.10% | 1.34% | 1.45% | 1.00% | 1.04% | 1.00% | 1.10% | -0.30% | 0.94% |
According to 1 Wall Street analysts, Nu Skin Enterprises's projected average Quarter EPS for Mar 24 is $0.05, with a low estimate of $0.05 and a high estimate of $0.05. This represents a -66.91% decrease compared to NUS previous annual EPS of $0.15 (Dec 23).
Nu Skin Enterprises Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HLF | Herbalife Nutrition | $7.10 | $18.83 | 165.21% | Buy |
| NUS | Nu Skin Enterprises | $7.21 | $11.00 | 52.57% | Strong Buy |
| PII | Polaris | $84.63 | $114.00 | 34.70% | Hold |
| IPAR | Inter Parfums | $117.85 | $157.00 | 33.22% | Buy |
| FLO | Flowers Foods | $23.68 | $22.67 | -4.27% | Hold |
| USNA | USANA Health Sciences | $39.96 | $38.00 | -4.90% | - |
NUS Forecast FAQ
What is NUS's price target?
Nu Skin Enterprises (NUS) average price target is $11 with a range of $11 to $11, implying a 52.78% from its last price of $7.2. The data is based on 0 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Nu Skin Enterprises stock go up soon?
According to Wall Street analysts' prediction for NUS stock, the company can go up by 52.78% (from the last price of $7.2 to the average price target of $11), up by 52.78% based on the highest stock price target, and up by 52.78% based on the lowest stock price target.
Can Nu Skin Enterprises stock reach $11?
NUS's average twelve months analyst stock price target of $11 does not support the claim that Nu Skin Enterprises can reach $11 in the near future.
What are Nu Skin Enterprises's analysts' financial forecasts?
Nu Skin Enterprises's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $1.76B (high $1.77B, low $1.74B), average EBITDA is $217.72M (high $234.33M, low $201.27M), average net income is $76.76M (high $86.34M, low $67.21M), average SG&A $1.13B (high $1.14B, low $1.13B), and average EPS is $0.704 (high $0.719, low $0.69). NUS's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.79B (high $1.81B, low $1.78B), average EBITDA is $189.08M (high $190.57M, low $187.8M), average net income is $52.17M (high $52.71M, low $51.72M), average SG&A $1.16B (high $1.17B, low $1.15B), and average EPS is $1.05 (high $1.06, low $1.04).
Did the NUS's actual financial results beat the analysts' financial forecasts?
Based on Nu Skin Enterprises's last annual report (Dec 2023), the company's revenue was $1.97B, which missed the average analysts forecast of $1.98B by -0.71%. Apple's EBITDA was $48.27M, missing the average prediction of $229.31M by -78.95%. The company's net income was $8.6M, missing the average estimation of $97.45M by -91.18%. Apple's SG&A was $1.29B, missing the average forecast of $1.38B by -6.45%. Lastly, the company's EPS was $0.17, missing the average prediction of $1.45 by -88.29%. In terms of the last quarterly report (Dec 2023), Nu Skin Enterprises's revenue was $488.64M, beating the average analysts' forecast of $476.39M by 2.57%. The company's EBITDA was $-28.886M, missing the average prediction of $50.26M by -157.48%. Nu Skin Enterprises's net income was $7.28M, missing the average estimation of $-1.242M by -686.22%. The company's SG&A was $326.36M, beating the average forecast of $307.4M by 6.17%. Lastly, the company's EPS was $0.15, missing the average prediction of $-0.025 by -700.00%